Pancreatic Cancer Research

ResearcherZhengzhou UniversityNo recent work listed

Shengyang Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1506-0615; OpenAlex author ID A5101956656. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 3

  1. Telomere-related prognostic biomarkers for survival assessments in pancreatic cancer. Co-author DOI 10.1038/s41598-023-37836-0↗
  2. Development and validation of a competing risk model for second primary pancreatic ductal adenocarcinoma: A population-based study. Co-author DOI 10.3389/fsurg.2022.934148↗
  3. Tumor Microenvironment Characteristics of Pancreatic Cancer to Determine Prognosis and Immune-Related Gene Signatures. Last author DOI 10.3389/fmolb.2021.645024↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaoyong Li · 2 shared papers, 2022–2023 · strength 0.34
  2. Genhao Zhang · 1 shared paper, 2023 · strength 0.18
  3. Lishan Song · 1 shared paper, 2022 · strength 0.15
  4. Xiao Xu · 1 shared paper, 2021 · strength 0.14
  5. Congjun Zhang · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.